ANN CHEN: Open Payments
NPI 1750358438 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 27 payments from 11 companies in 2025. Trend: 2023 $605 · 2024 $515 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $194 |
| Madrigal Pharmaceuticals | 4 | $172 |
| Boston Scientific Corporation | 1 | $144 |
| ABBVIE INC. | 6 | $107 |
| PFIZER INC. | 3 | $50 |
| Corcept Therapeutics | 2 | $42 |
| Amgen Inc. | 1 | $33 |
| GENZYME CORPORATION | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
Products named: TREMFYA, REZDIFFRA, General - Biliary Devices, SKYRIZI, Korlym, REPATHA, LINZESS, RINVOQ.
Industry payments across MD — which companies pay providers there.
